Coagulopathies and Ischemic Stroke

S. M. Koleilat, Bruce M Coull

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

In ischemic stroke coagulopathies are characterized by a condition in which blood is too quick to clot. Such coagulation abnormalities may be genetic or acquired. Coagulation abnormalities are identified as the cause of ischemic stroke in less than 1% of unselected series. Accordingly, in the vast majority of patients with ischemic stroke an extensive evaluation to identify a coagulopathy is not warranted. In few specific setting, testing for a coagulopathy may provide diagnostic evidence for an otherwise unexplained stroke.

Original languageEnglish (US)
Title of host publicationPrimer on Cerebrovascular Diseases
Subtitle of host publicationSecond Edition
PublisherElsevier Inc.
Pages587-590
Number of pages4
ISBN (Print)9780128030585
DOIs
StatePublished - Mar 7 2017

Fingerprint

Stroke

Keywords

  • Antithrombin
  • Coagulation abnormalities
  • Fibrinolytic abnormalities
  • Ischemic stroke
  • Protein C
  • Protein S

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Koleilat, S. M., & Coull, B. M. (2017). Coagulopathies and Ischemic Stroke. In Primer on Cerebrovascular Diseases: Second Edition (pp. 587-590). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-803058-5.00115-6

Coagulopathies and Ischemic Stroke. / Koleilat, S. M.; Coull, Bruce M.

Primer on Cerebrovascular Diseases: Second Edition. Elsevier Inc., 2017. p. 587-590.

Research output: Chapter in Book/Report/Conference proceedingChapter

Koleilat, SM & Coull, BM 2017, Coagulopathies and Ischemic Stroke. in Primer on Cerebrovascular Diseases: Second Edition. Elsevier Inc., pp. 587-590. https://doi.org/10.1016/B978-0-12-803058-5.00115-6
Koleilat SM, Coull BM. Coagulopathies and Ischemic Stroke. In Primer on Cerebrovascular Diseases: Second Edition. Elsevier Inc. 2017. p. 587-590 https://doi.org/10.1016/B978-0-12-803058-5.00115-6
Koleilat, S. M. ; Coull, Bruce M. / Coagulopathies and Ischemic Stroke. Primer on Cerebrovascular Diseases: Second Edition. Elsevier Inc., 2017. pp. 587-590
@inbook{2d0a178940714bf8a574cc7fe7b402ff,
title = "Coagulopathies and Ischemic Stroke",
abstract = "In ischemic stroke coagulopathies are characterized by a condition in which blood is too quick to clot. Such coagulation abnormalities may be genetic or acquired. Coagulation abnormalities are identified as the cause of ischemic stroke in less than 1{\%} of unselected series. Accordingly, in the vast majority of patients with ischemic stroke an extensive evaluation to identify a coagulopathy is not warranted. In few specific setting, testing for a coagulopathy may provide diagnostic evidence for an otherwise unexplained stroke.",
keywords = "Antithrombin, Coagulation abnormalities, Fibrinolytic abnormalities, Ischemic stroke, Protein C, Protein S",
author = "Koleilat, {S. M.} and Coull, {Bruce M}",
year = "2017",
month = "3",
day = "7",
doi = "10.1016/B978-0-12-803058-5.00115-6",
language = "English (US)",
isbn = "9780128030585",
pages = "587--590",
booktitle = "Primer on Cerebrovascular Diseases",
publisher = "Elsevier Inc.",
address = "United States",

}

TY - CHAP

T1 - Coagulopathies and Ischemic Stroke

AU - Koleilat, S. M.

AU - Coull, Bruce M

PY - 2017/3/7

Y1 - 2017/3/7

N2 - In ischemic stroke coagulopathies are characterized by a condition in which blood is too quick to clot. Such coagulation abnormalities may be genetic or acquired. Coagulation abnormalities are identified as the cause of ischemic stroke in less than 1% of unselected series. Accordingly, in the vast majority of patients with ischemic stroke an extensive evaluation to identify a coagulopathy is not warranted. In few specific setting, testing for a coagulopathy may provide diagnostic evidence for an otherwise unexplained stroke.

AB - In ischemic stroke coagulopathies are characterized by a condition in which blood is too quick to clot. Such coagulation abnormalities may be genetic or acquired. Coagulation abnormalities are identified as the cause of ischemic stroke in less than 1% of unselected series. Accordingly, in the vast majority of patients with ischemic stroke an extensive evaluation to identify a coagulopathy is not warranted. In few specific setting, testing for a coagulopathy may provide diagnostic evidence for an otherwise unexplained stroke.

KW - Antithrombin

KW - Coagulation abnormalities

KW - Fibrinolytic abnormalities

KW - Ischemic stroke

KW - Protein C

KW - Protein S

UR - http://www.scopus.com/inward/record.url?scp=85028291174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028291174&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-803058-5.00115-6

DO - 10.1016/B978-0-12-803058-5.00115-6

M3 - Chapter

AN - SCOPUS:85028291174

SN - 9780128030585

SP - 587

EP - 590

BT - Primer on Cerebrovascular Diseases

PB - Elsevier Inc.

ER -